期刊文献+

GFP mRNA在树突状细胞中的转染及其影响因素分析 被引量:6

Transfection of GFP mRNA in dendritic cells and analysis of some factors involved
下载PDF
导出
摘要 目的:探讨绿色荧光蛋白(GFP)mRNA在树突状细胞(DC)中的转染及其影响因素。方法:选用gfp报告基因,在体外利用含T7RNA聚合酶的mMESSAGERNA转录试剂盒,合成含有帽子结构的GFPmRNA,通过酵母多聚A聚合酶加尾,制备结构完整的GFPmRNA。与此同时,从人的外周血液中分离单核细胞,并在体外经GM-CSF和IL-4刺激分化为DC。通过转染试剂介导将合成的GFPmRNA转染到DC内并使其表达。采用流式细胞术检测其转染效率和表达水平。结果:体外合成GFPmRNA,经转染试剂介导,实现了gfp基因在DC中的表达。不同的转染试剂、mRNA用量和细胞密度对mRNA的转染效率有较大的影响。采用Transmes-sengerTransfectionKit转染试剂,1μgGFPmRNA在200μLX-VIVO-15无血清培养基中的转染密度为2.5×109/L的DC,可获得较好的转染效果(转染效率达27%以上)。结论:在适当的条件下,通过mRNA转染DC可获得较高的转染效率。 AIM: To investigate the transfection of green fluorescent protein (GFP) mRNA in dendritic cells (DC) and analyze some factors which influence the transfection efficiency. METHODS: GFP (as a report gene) mRNA with cap was synthesized, in vitro, with mMESSAGE RNA Transcription Kit containing T7 RNA polymerase, and then the poly(A) was added to the GFP caped-mRNA by yeast poly(A) polymerase. DC were generated from the monocytes isolated from human peripheral blood by stimulation of GM-CSF and IL-4. The GFP mRNA was transfected into DC mediated by transfection reagent. The transfection efficiency and the expression levels were measured by flow cytometry. RESULTS: GFP expression in DC has been obtained by transfecting its mRNA synthesized in vitro, The transfection reagents, mRNA concentnations and cell densities have the significant effects on the transfection. The high level of transfection efficiency ( up to 27% ) was obtained using Transmessenger Transfection Kit with 1 μg gfp mRNA in 200 μL X-VIVO-15 serum-free medium at the cell density of 2.5 × 10^9/L. CONCLUSION: The high-level transfection efficiency of gfp gene in DC could been achieved by using GFP mRNA in the optimum transfection conditions.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2006年第6期716-719,共4页 Chinese Journal of Cellular and Molecular Immunology
关键词 树突状细胞 MRNA GFP 基因转染 dendritic cells mRNA GFP gene transfection
  • 相关文献

参考文献9

  • 1Steinman RM.The dendritic cell system and its role in immunogenicity[J].Annu Rev Immunol,1991,9:271-296.
  • 2Zhang M,Tang H,Guo Z,et al.Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells[J].Nat Immunol,2004,5(11):1124-1133.
  • 3贺兰湘,张桂梅,冯作化.负载不同形式肝癌抗原的树突状细胞抑瘤功能的比较[J].细胞与分子免疫学杂志,2005,21(1):100-102. 被引量:5
  • 4Nestle FO,Alijagic S,Gilliet M,et al.Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells[J].Nat Med,1998,4(3):328-332.
  • 5Abdel-Wahab Z,Kalady MF,Emani S,et al.Induction of anti-melanoma CTL response using DC transfected with mutated mRNA encoding full-length Melan-A/MART-1 antigen with an A27L amino acid substitution[J].Cell Immunol,2003,224(2):86-97.
  • 6Saeboe-Larssen S,Fossberg E,Gaudernack G.mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T lymphocyte responses against the telomerase catalytic subunit (hTERT)[J].J Immunol Methods,2002,259(1-2):191-203.
  • 7Bontkes HJ,Ruizendaal JJ,Schreurs MW,et al.Antigen gene transfer to human plasmacytoid dendritic cells using recombinant adenovirus and vaccinia virus vectors[J].Cell Oncol,2005,27(3):175-182.
  • 8Pickl WF,Majdic O,Kohl P,et al.Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes[J].J Immonol,1996,157:3850-3859.
  • 9Kalady MF,Onaitis MW,Emani S,et al.Dendritic cells pulsed with pancreatic cancer total tumor RNA generate specific antipancreatic cancer T cells[J].J Gastrointest Surg,2004,8(2):175-181.

二级参考文献13

  • 1Stift A, Friedl J, Dubsky P, et al. Dendritic cell-based vaccination in solid cancer[J]. J Clin Oncol, 2003, 21(1): 135- 142.
  • 2Marten A, Flieger D, Renoth S, et al. Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial[J]. Cancer Immunol Immunother, 2002, 51(11-12): 637-644.
  • 3Lambert LA, Gibson GR, Maloney M, et al. Intranodal immunization with tumor lysate-pulsed dendritic cells enhances protective antitumor immunity[J]. Cancer Res, 2001, 61(2): 641-646.
  • 4Blachere NE, Li ZH, Rajiv Y, et al. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity[J]. J Exp Med, 1997, 186 (8): 1315-1322.
  • 5Vendetti S, Chai JG, Dyson J, et al. Anergic T cells inhibit the antigen-presenting function of dendritic cells[J]. J Immunol, 2000, 165: 1175-1181.
  • 6Curiel TJ, Wei S, Dong H, et al. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity[J]. Nat Med, 2003, 9(5): 562-567.
  • 7Kakumu S, Ito S, Ishikawa T, et al. Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection[J]. J Gastroenterol Hepatol, 2000, 15(4): 431-436.
  • 8Kohrgruber N, Halanek N, Winter D, et al. Survival, maturation, and function of CD11c- and CD11c+ peripheral blood dendritic cells are differentially regulated by cytokines[J]. J Immunol, 1999, 163: 3250-3259.
  • 9Ridgway D. The first 1000 dendritic cell vaccines[J]. Cancer Invest, 2003, 21(6): 873-886.
  • 10DeMatos P, Abdel-Wahab Z, Vervaert C, et al. Pulsing of dendritic cells with cell lysates from either B16 melanoma or MCA-106 fibrosarcoma yields equally effective vaccines against B16 tumors in mice[J]. J Surg Oncol, 1998, 68(2): 79-91.

共引文献4

同被引文献26

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部